Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Thoracent is a medical device company that specializes in the development of advanced procedural kits for thoracic and pulmonary medicine. The company is best known for the Thoracent Pleural Drainage System, a specialized catheter system used for the management of pleural effusions and pneumothorax. Designed to enhance safety and ease of use for clinicians, the system incorporates features to minimize the risk of needle-stick injuries and improve fluid drainage efficiency. Thoracent was founded by interventional pulmonologists to address unmet needs in bedside thoracic procedures. In 2013, the company was acquired by Teleflex, a global provider of medical technologies, which now markets the Thoracent product line as part of its interventional lung health portfolio.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Thoracent.